Becton, Dickinson and Company
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Thomas E. Polen
- Full Time Employees
- 72,000
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 1 Becton Drive Franklin Lakes NJ United States 07417-1880
- IPO Date
- Sep 25, 1963
- CIK
- 0000010795
- Website
- bd.com
- Similar Companies
- Business
- Becton, Dickinson and Company (BDX) manufactures and distributes medical devices, instrument systems, and reagents worldwide. The company develops, produces, and sells a broad portfolio of products including syringes, catheters, infusion therapy devices, and diagnostic systems; safety-engineered sharps and vascular access products; BD Alaris infusion pumps and Pyxis medication management solutions; BD FACSAria flow cytometers and Rhapsody single-cell analysis platforms; and laboratory automation systems such as BD Kiestra and BD Synapsys informatics. BD operates in three main segments—BD Medical, BD Life Sciences, and BD Interventional—serving healthcare facilities, laboratories, pharmaceutical companies, and research institutions across North America, Europe, Asia-Pacific, and emerging markets. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD maintains a global presence with manufacturing facilities in more than 50 countries. In recent developments, BD completed the spin-off of its Biosciences solution business into a standalone entity in early 2025, enabling focused growth in high-margin diagnostics and cell analysis; the company also expanded its partnership with GE HealthCare for integrated medication management technologies and launched new Alaris iPC infusion pump features to enhance cybersecurity and interoperability.
Company News
3,815 Becton, Dickinson and Company $BDX Shares Bought by CFS Investment Advisory Services LLC
Becton, Dickinson and Company $BDX Position Trimmed by Louisbourg Investments Inc.
Becton, Dickinson and Company $BDX Stock Sold by Forbes J M & Co. LLP
Becton, Dickinson and Company $BDX Position Boosted by Birch Hill Investment Advisors LLC
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?
Becton, Dickinson and Company $BDX Shares Acquired by YHB Investment Advisors Inc.
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026
BD and Global Health Leaders Call for Accelerated Maternal Life Saving Measures Worldwide
BDX Expands U.S. Manufacturing With $19B Healthcare Investment
BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results
Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing
BD Celebrates 65 Years of Manufacturing, Innovation and Community Partnership in Canaan
BD Appoints Ferass Abuzaina as Worldwide President of Surgery
BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience
Trump says Becton Dickinson to invest $3 billion to expand US medical product manufacturing
Becton, Dickinson and Company $BDX Shares Sold by Park National Corp OH
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth